In a systematic review of 18 studies and a meta-analysis of 14 studies, the risk of colorectal cancer was shown to be moderately elevated in BRCA1 (a 1.49-fold higher risk of CRC in BRCA1 mutation carriers) but not in BRCA2 mutation carriers [53]. The gene discussed is BRCA2; the disease is colorectal cancer.